Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients
AssigneeSolvay Pharmaceuticals GmbH
InventorsWerner L. M. Cautreels, Claus Rudolf Steinborn, Heinz Guenter Krause, Steven David Caras, Egbertus Hendrikus Evert Biesheuvel, Albertus Hermannus Dirk Plekkenpol
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of cilansetron for the treatment of non-obstipative male IBS patients.
Claims8
A method of inhibiting preparations for the treatment and/or prophylaxis of irritable bowel syndrome (=IBS) in a non-obstipative male patient, said method comprising administering to said patient a pharmaceutical composition comprising an effective IBS inhibiting amount of cilansetron or a pharmacologically acceptable acid addition salt thereof or a solvate thereof.
A method of treating a human patient suffering from irritable bowel syndrome (=IBS), said method comprising administering a pharmaceutical composition comprising at least one 5HT3-receptor antagonist to said patient three times a day.
Dependencies are inferred from the claim text.